Various alphabetized medical records

Life Sciences Antitrust & Competition

CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.


  • 01
    CRA assesses class certification, market power, anticompetitive impact, and damages in alleged "No-AG" pay-for-delay suit
    CRA is retained by a major pharmaceutical manufacturer and a generic first filer in a suit alleging a pay-for-delay settlement. Rather than alleging a cash...
    View engagement
  • 02
    CRA assesses pharmaceutical supply agreements for potential competitive benefits
    A manufacturer of a Schedule II product entered into sequential patent settlement agreements that included product supply obligations.  Following allegations...
    View engagement
  • 03
    CRA conducts market definition analysis
    CRA was retained by Defendants in this pay-for-delay litigation that went to trial. Plaintiffs included direct purchasers, indirect purchasers, and opt-out...
    View engagement

Subscribe to receive our latest Insights.